Covid-19: EU panel ‘convinced’ AstraZeneca benefit outweighs risk factor
The European Medicines Agency urged governments not to halt use of the vaccine at a time when the pandemic is still taking thousands of lives each day.
The European Union’s drug regulator insisted on Tuesday that there is “no indication” the AstraZeneca vaccine causes blood clots as governments around the world faced the grimmest of dilemmas: push on with a vaccine known to save lives or suspend its use over reports of clotting in some recipients.
The European Medicines Agency urged governments not to halt use of the vaccine at a time when the pandemic is still taking thousands of lives each day. And already there are concerns that even brief suspensions could have disastrous effects on confidence in inoculation campaigns the world over, many of which are already struggling to overcome logistical hurdles and widespread hesitancy about experimental vaccines.
“We are still firmly convinced that the benefits of the AstraZeneca vaccine in preventing Covid-19 with its associated risk of hospitalisation and death outweigh the risk of the side effects,” said Emer Cooke, the head of the agency.
Prime Minister Narendra Modi urged officials to ensure seamless and... READ MORE
India's crisis highlights the need to increase investment in the... READ MORE
Measures taken by government successful in controlling spread of the ... READ MORE
Previous studies had shown it was linked to a higher likelihood of... READ MORE
The three countries would be classified as 'extremely high risk'... READ MORE
Coincidentally, Pakistan Foreign Minister Shah Mahmood Qureshi is... READ MORE
It is the first time in 400 days that people can travel quarantine-... READ MORE
The helicopter will rise for about six seconds, hover and rotate for... READ MORE